Suspected COVID-19 patient who died tests negative in Camarines Sur | Inquirer News

Suspected COVID-19 patient who died tests negative in Camarines Sur

PILI, Camarines Sur –– The 26-year-old suspected coronavirus (COVID-19) patient, who died on Saturday, has tested negative for the virus in Naga City.

The patient, who was from Ragay town, reportedly died due to severe pneumonia.

Ragay Mayor Thaddy Ramos, said they have received the official result issued by the Bicol Regional Diagnostic and Reference Laboratory in Legazpi City regarding the suspected case.

Article continues after this advertisement

“The 26-year-old patient was NEGATIVE for SARS-Cov 2 (causative agent of COVID-19), thus, we continue to be COVID-19-free here in Ragay,” he said.

Ramos said that even with the negative result, he encouraged everyone to continue following the precautionary measures recommended by the Department of Health to avoid the spread of the virus.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, Philippine news updates, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.